Back
Day Range
$114.40
$114.70
52-Week Range
$47.86
$114.91
Volume
1,377,509
50D / 200D Avg
$86.59
/
$77.34
Prev Close
$114.60
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -29.3 | 0.3 |
| P/B | 16.7 | 2.9 |
| ROE % | -53.4 | 3.7 |
| Net Margin % | -1027.3 | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.2 | 0.2 |
Analyst Price Target
Hold
$110.42
-3.7%
Low: $82.00
High: $120.00
Forward EPS
-$3.52
Est. Revenue
87 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2029 |
$3.87
$1.35 – $8.12
|
740 M | 4 |
| FY2028 |
$0.33
-$0.48 – $1.22
|
460 M | 10 |
| FY2027 |
-$1.61
-$5.47 – $1.86
|
270 M | 10 |
Key Takeaways
Debt/Equity of 0.24 — conservative balance sheet
Negative free cash flow of -212.59M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)-79.35%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-53.42%
ROIC-38.07%
Net Margin-1027.25%
Op. Margin-1135.61%
Safety
Debt / Equity
0.24
Current Ratio4.44
Interest Coverage-10.45
Valuation
P/E Ratio
-29.30
P/B Ratio16.67
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -79.35% | Revenue Growth (3Y) | -55.05% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 22.29M | Net Income (TTM) | -228.93M |
| ROE | -53.42% | ROA | -37.90% |
| Gross Margin | 70.03% | Operating Margin | -1135.61% |
| Net Margin | -1027.25% | Free Cash Flow (TTM) | -212.59M |
| ROIC | -38.07% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.24 | Current Ratio | 4.44 |
| Interest Coverage | -10.45 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -29.30 | P/B Ratio | 16.67 |
| P/S Ratio | 300.95 | PEG Ratio | -0.15 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 6.71B | Enterprise Value | 6.72B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 22.29M | 107.94M | 110.32M | 0.0 | 0.0 |
| Net Income | -228.93M | -107.35M | -70.69M | -188.68M | -64.97M |
| EPS (Diluted) | -4.07 | -2.00 | -1.47 | -4.28 | -1.94 |
| Gross Profit | 15.61M | 102.75M | 110.32M | -2.22M | 0.0 |
| Operating Income | -253.08M | -137.57M | -89.88M | -191.26M | -65.02M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 603.99M | 711.33M | 825.13M | 313.82M | 128.78M |
| Total Liabilities | 201.64M | 256.54M | 339.75M | 108.86M | 250.30M |
| Shareholders' Equity | 402.35M | 454.79M | 485.38M | 204.95M | -121.52M |
| Total Debt | 96.26M | 54.08M | 97.63M | 88.13M | 0.0 |
| Cash & Equivalents | 80.26M | 105.68M | 394.58M | 64.18M | 30.83M |
| Current Assets | 462.18M | 599.31M | 716.36M | 266.86M | 112.81M |
| Current Liabilities | 104.20M | 125.41M | 118.24M | 56.69M | 14.85M |